Alzamend Neuro (ALZN) Shares Outstanding (2020 - 2026)

Alzamend Neuro has disclosed Shares Outstanding (Entity) across 7 years of filings, most recently posting $3.3 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 640.27% year-over-year to $3.3 million; the TTM figure through Apr 2026 stood at $3.3 million (up 640.27% YoY), while the FY2026 annual figure was $3.3 million, up 640.27% from the prior year.
• Shares Outstanding (Entity) came in at $3.3 million for Q2 2026 at Alzamend Neuro, down from $3.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $3.8 million in Q1 2026 to a low of $66745.0 in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $858032.2, with a median of $77781.0 recorded in 2023.
• Year-over-year, Shares Outstanding (Entity) climbed 1.53% in 2023 and surged 2100.6% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $70739.0 in 2022, then climbed by 11.84% to $79118.0 in 2023, then surged by 395.98% to $392407.0 in 2024, then surged by 868.79% to $3.8 million in 2025, then declined by 12.22% to $3.3 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $3.3 million in Q2 2026, $3.8 million in Q1 2026, and $3.8 million in Q4 2025.